Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Antidepressants or Antipsychotics in Preventing Psychosis: Fluoxetine vs Aripiprazole Comparative Trial (FACT)

NCT02357849 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.

NCT NCT02357849
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02357849 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Antidepressants or Antipsychotics in Preventing Psychosis: Fluoxetine vs Aripiprazole Comparative Trial (FACT)
Lead sponsor
Northwell Health
Phase
Phase 4
Overall status
Terminated
Start date
July 31, 2014
Completion date
April 4, 2022
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attenuated psychosis syndrome